Back to top
more

Insulet (PODD)

(Delayed Data from NSDQ)

$175.95 USD

175.95
945,611

+3.70 (2.15%)

Updated May 30, 2024 04:00 PM ET

After-Market: $175.94 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment

Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.

Insulet (PODD) Gains As Market Dips: What You Should Know

Insulet (PODD) closed the most recent trading day at $319.91, moving +0.34% from the previous trading session.

3 Reasons Growth Investors Will Love Insulet (PODD)

Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.

Here's Why You Should Retain Amedisys (AMED) Stock for Now

Amedisys's (AMED) share price is likely to grow following an impressive fourth-quarter 2022 performance and new partnerships.

Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

Bruker Corporation (BRKR) outperforms the industry and the S&P 500 due to impressive quarterly results and segmental prospects.

Insulet (PODD) Gains But Lags Market: What You Should Know

Insulet (PODD) closed at $312.90 in the latest trading session, marking a +0.52% move from the prior day.

Insulet (PODD) Benefits From Omnipod 5 Launch, Expansion

Insulet (PODD) witnesses continued uptake of Omnipod through the U.S. pharmacy channel.

Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Analyst Blog Highlights Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor

Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor are included in this Analyst Blog.

Tirthankar Chakraborty headshot

Fed Policy Pause & Yellen's Assurance Buoy Wall Street: 5 Picks

Thanks to the Fed's willingness to pause its interest rate hikes, it's prudent for investors to place their bets on growth stocks like Comfort Systems USA (FIX), Hershey (HSY), Wynn Resorts (WYNN), Insulet (PODD), and Lattice Semiconductor (LSCC).

Insulet (PODD) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Insulet (PODD) closed at $311.49, marking a -1.16% move from the previous day.

Insulet (PODD) Stock Moves -1.05%: What You Should Know

In the latest trading session, Insulet (PODD) closed at $309.09, marking a -1.05% move from the previous day.

Insulet (PODD) Gains But Lags Market: What You Should Know

In the latest trading session, Insulet (PODD) closed at $312.36, marking a +1.45% move from the previous day.

3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)

Insulet (PODD) could produce exceptional returns because of its solid growth attributes.

Company News for Mar 14, 2023

Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC.

Insulet (PODD) Stock Moves -0.97%: What You Should Know

Insulet (PODD) closed at $280.36 in the latest trading session, marking a -0.97% move from the prior day.

Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Insulet (PODD) could produce exceptional returns because of its solid growth attributes.

Insulet (PODD) Upgraded to Buy: What Does It Mean for the Stock?

Insulet (PODD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Teladoc Health (TDOC) Down 8.1% Since Q4 Earnings Release

Teladoc Health's (TDOC) fourth-quarter results bear the brunt of escalating expenses. Management expects 2023 revenues within $2,550-$2,675 million, way higher than the 2022 figure.

Insulet (PODD) Q4 Earnings Beat Estimates, Margins Down

Insulet's (PODD) Q4 performance benefits from record quarterly U.S. and Total Omnipod new customer starts.

Insulet (PODD) Q4 Earnings and Revenues Beat Estimates

Insulet (PODD) delivered earnings and revenue surprises of 129.17% and 11.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Insulet (PODD) Outpaces Stock Market Gains: What You Should Know

Insulet (PODD) closed the most recent trading day at $298.61, moving +1.28% from the previous trading session.

Insulet (PODD) to Report Q4 Earnings: What's in the Cards?

In Drug Delivery, Insulet (PODD) is expected to have faced higher manufacturing costs in Q4.

Insulet (PODD) Stock Sinks As Market Gains: What You Should Know

Insulet (PODD) closed at $289.36 in the latest trading session, marking a -0.96% move from the prior day.

Insulet (PODD) Outpaces Stock Market Gains: What You Should Know

Insulet (PODD) closed the most recent trading day at $290.53, moving +1.12% from the previous trading session.